Cytokinetics | CYTK - Operating Expenses


Cytokinetics reported $196.12M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Acadia Pharmaceuticals USD 266.6M 23.72M Dec/2025
Amgen USD 5.9B 773M Dec/2025
Arca Biopharma USD 34.43M 326K Dec/2025
Bayer EUR 10.33B 126M Dec/2025
Biogen USD 1.88B 81.4M Sep/2025
Brainstorm Cell Therapeutics USD 2.24M 197K Dec/2025
Bristol-Myers Squibb USD 8.3B 10.25B Dec/2025
Capricor Therapeutics USD 29.16M 2.87M Dec/2025
Cytokinetics USD 196.12M 27.43M Dec/2025
Eisai JPY 199.9B 16.22B Dec/2025
Eli Lilly USD 10.31B 1.09B Dec/2025
Exelixis USD 362.75M 21.35M Dec/2025
Geron USD 58.8M 2.31M Dec/2025
Halozyme Therapeutics USD 211.07M 74.73M Dec/2025
Ionis Pharmaceuticals USD 418M 101.1M Dec/2025
Ligand Pharmaceuticals USD 8.29M 32.17M Sep/2025
Merck USD 10.16B 558M Dec/2025
Novartis USD 9.8B 61M Dec/2025
Pfizer USD 12.91B 79.89B Dec/2025
Regeneron Pharmaceuticals USD 2.99B 27.97B Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Sanofi EUR 10.51B 1.21B Dec/2025